Michael G Shlipak Selected Research

alpha-1-microglobulin

1/2021	Urine Alpha-1-Microglobulin Levels and Acute Kidney Injury, Mortality, and Cardiovascular Events following Cardiac Surgery.
10/2019	Association of Statin Use With Kidney Damage and Function Among HIV-Infected Men.
1/2019	Associations of Urine Biomarkers with Kidney Function Decline in HIV-Infected and Uninfected Men.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael G Shlipak Research Topics

Disease

96	Chronic Renal Insufficiency 04/2022 - 03/2005
61	Cardiovascular Diseases (Cardiovascular Disease) 03/2022 - 04/2003
55	Heart Failure 12/2022 - 01/2003
43	Kidney Diseases (Kidney Disease) 10/2022 - 12/2005
38	Albuminuria 01/2022 - 11/2003
35	Hypertension (High Blood Pressure) 01/2022 - 09/2003
32	Atherosclerosis 07/2022 - 12/2005
28	Inflammation (Inflammations) 07/2022 - 01/2003
28	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 03/2008
19	HIV Infections (HIV Infection) 05/2021 - 11/2007
19	Coronary Disease (Coronary Heart Disease) 01/2020 - 01/2003
18	Renal Insufficiency (Renal Failure) 10/2022 - 09/2002
18	Chronic Kidney Failure (Chronic Renal Failure) 07/2022 - 08/2006
15	Coronary Artery Disease (Coronary Atherosclerosis) 08/2017 - 01/2005
14	Myocardial Infarction 03/2022 - 01/2003
13	Fibrosis (Cirrhosis) 07/2022 - 01/2014
13	Proteinuria 01/2022 - 11/2008
12	Stroke (Strokes) 07/2022 - 05/2005
9	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 10/2013
8	Infections 01/2021 - 12/2005
7	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2021 - 09/2004
6	Frailty 03/2022 - 12/2013
6	Insulin Resistance 05/2016 - 11/2007
6	Heart Diseases (Heart Disease) 10/2013 - 01/2003
5	Atrial Fibrillation 01/2021 - 09/2004
5	Diabetes Mellitus 12/2020 - 05/2007
5	Coinfection 04/2017 - 11/2007
5	Peripheral Arterial Disease 01/2017 - 04/2004
4	Hypotension (Low Blood Pressure) 01/2022 - 01/2003
4	Anemia 01/2016 - 11/2004
3	Weight Loss (Weight Reduction) 02/2016 - 07/2006
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 07/2015 - 03/2010
3	Obesity 11/2014 - 12/2009
3	Vascular Calcification 12/2012 - 08/2006
3	Ischemia 11/2009 - 01/2003
2	Disease Progression 07/2022 - 07/2017
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2021
2	Syncope (Fainting) 01/2022 - 01/2022
2	Hyperkalemia 01/2022 - 06/2003
2	Bradycardia 01/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

107	CreatinineIBA 12/2022 - 09/2002
91	Cystatin CIBA 12/2022 - 01/2005
77	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2003
44	AlbuminsIBA 01/2022 - 11/2003
17	Fibroblast Growth Factor-23IBA 01/2022 - 03/2010
15	UromodulinIBA 07/2022 - 06/2009
15	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2022 - 09/2007
14	C-Reactive ProteinIBA 07/2012 - 01/2003
12	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2022 - 03/2017
12	Proteins (Proteins, Gene)FDA Link 07/2022 - 06/2009
12	MineralsIBA 10/2021 - 05/2010
11	pro-brain natriuretic peptide (1-76)IBA 04/2022 - 09/2007
11	Interleukin-18 (Interleukin 18)IBA 01/2022 - 01/2014
10	Troponin T (Troponin T1)IBA 04/2022 - 05/2013
10	Antihypertensive Agents (Antihypertensives)IBA 10/2021 - 06/2005
10	Tenofovir (Viread)FDA Link 01/2018 - 06/2011
10	HDL CholesterolIBA 04/2017 - 01/2003
9	Serum AlbuminIBA 01/2022 - 01/2012
8	Lipocalin-2IBA 01/2022 - 12/2012
8	alpha-2-HS-GlycoproteinIBA 05/2016 - 04/2006
8	Glucose (Dextrose)FDA LinkGeneric 06/2014 - 09/2004
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 01/2003
7	Hormones (Hormone)IBA 01/2019 - 04/2003
7	Estrogens (Estrogen)FDA Link 01/2005 - 01/2003
7	Progestins (Progestagens)IBA 01/2005 - 01/2003
6	Parathyroid Hormone (Parathormone)IBA 10/2021 - 02/2009
6	Hemoglobins (Hemoglobin)IBA 01/2019 - 11/2004
6	Bicarbonates (Hydrogen Carbonate)IBA 01/2019 - 10/2014
6	RNA (Ribonucleic Acid)IBA 01/2019 - 06/2010
5	DiureticsIBA 06/2022 - 01/2017
5	Triglycerides (Triacylglycerol)IBA 04/2017 - 01/2008
5	HDL LipoproteinsIBA 09/2016 - 11/2007
5	LDL CholesterolIBA 11/2014 - 11/2003
5	Fibrinogen (Factor I)FDA Link 07/2012 - 01/2003
5	Interleukin-6 (Interleukin 6)IBA 06/2010 - 01/2003
5	LipidsIBA 10/2009 - 11/2003
4	Epidermal Growth Factor (EGF)IBA 07/2022 - 01/2018
4	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022 - 08/2017
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 06/2003
4	CholesterolIBA 11/2019 - 04/2006
4	Collagen Type III (Type III Collagen)IBA 10/2019 - 10/2015
4	Lipoproteins (Lipoprotein)IBA 01/2014 - 12/2003
4	Uric Acid (Urate)IBA 07/2012 - 08/2007
3	Chitinase-3-Like Protein 1IBA 07/2022 - 01/2019
3	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2022 - 01/2020
3	Vitamin D FDA LinkGeneric 10/2021 - 12/2011
3	alpha-1-microglobulinIBA 01/2021 - 01/2019
3	Growth Differentiation Factor 15IBA 07/2020 - 11/2019
3	insulin receptor-related receptor (IRR)IBA 01/2020 - 01/2010
3	Pharmaceutical PreparationsIBA 01/2020 - 06/2003
3	PotassiumIBA 01/2019 - 09/2016
3	CalciumIBA 01/2019 - 01/2010
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2017 - 10/2002
3	oxidized low density lipoproteinIBA 01/2014 - 11/2003
2	ChitinasesIBA 07/2022 - 01/2018
2	Type II Tumor Necrosis Factor ReceptorsIBA 01/2022 - 01/2022
2	ElectrolytesIBA 01/2022 - 01/2022
2	hydroxide ionIBA 10/2021 - 04/2017

Therapy/Procedure

22	Therapeutics 10/2022 - 04/2003
3	Secondary Prevention 01/2019 - 01/2003